4th Edition of International Heart Congress
June 22-24,2026 | Hybrid Event
Vein Graft Disease
Vein graft disease is a condition that often arises after coronary artery bypass surgery, where a vein from the patient's leg is used to create a bypass around a blocked coronary artery. Over time, these grafts can undergo pathological changes, leading to the development of vein graft disease. The process involves a series of complex events, including inflammation, oxidative stress, and the formation of atherosclerotic plaques within the graft. As vein graft disease progresses, it can compromise blood flow to the heart, ultimately impacting the success of the bypass procedure. Researchers and clinicians focus on understanding the molecular and cellular mechanisms underlying vein graft disease to develop strategies for prevention and intervention, aiming to improve the long-term outcomes of coronary artery bypass grafting procedures.
Shuping Zhong
University of Southern California, United States
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Ishan Abdullah
George Washington University School of Medicine and Health Sciences, United States
Sana Tariq
Manchester University NHS Foundation Trust, United Kingdom
Achi Kamaraj
Royal Brisbane and Women’s Hospital, Austria
Agustin Joison
Cordoba Catholic University, ArgentinaSubmit your abstract Today
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of Life, the skinny on statins and beyond !
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Study of pathological cardiac hypertrophy regression
Shuping Zhong, University of Southern California, United States
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Atypical takotsubo cardiomyopathy presenting as st-elevation myocardial infarction
Sana Tariq, Manchester University NHS Foundation Trust, United Kingdom